folder Filed in Funding daily
Biotech company LYNK Pharmaceuticals raised $50 million in Series B round
By Tsani Gramatikova access_time 1 min read

What is LYNK Pharmaceuticals?

LYNK Pharmaceuticals is a biotech company.

What does LYNK Pharmaceuticals do?

The company focuses on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases.

Who owns LYNK Pharmaceuticals?

 Jardo Chein, Jun Wang, Michael Vazquez and Zhao-Kui (ZK) Wan founded the company in 2018.

How much has LYNK Pharmaceuticals raised?

The company announced the completion of Series B financing of $50 million.

Who has invested in LYNK Pharmaceuticals?

Med-Fine Capital and HEDA Ventures are the most recent investors.

What domain name does LYNK Pharmaceuticals operate on?

LYNK Pharmaceuticals is operating on the domain name.

Related reads

If you have $500k to invest in your brand today, what is the best way to spend it?

13 Entrepreneurs explain how they came up with their brand name

The fastest-growing companies in the World and their domain name choices

branding domain domain name domains